Immunological effect of cycloheximide in mice

Area of Science:

• Immunology
• Pharmacology

Background:

• The immune system's complex regulatory mechanisms are crucial for effective defense.
• Understanding how pharmacological agents influence immune responses is vital for therapeutic development.

Purpose of the Study:

• To investigate the dose-dependent effects of cycloheximide on specific mouse immune responses.
• To determine the impact of cycloheximide on both humoral (antibody production) and cell-mediated (delayed hypersensitivity) immunity.

Main Methods:

• Mice were administered varying intraperitoneal (i.p.) doses of cycloheximide.
• The direct splenic plaque-forming cell (PFC) assay was used to measure the humoral immune response to sheep red blood cells.
• The delayed-type hypersensitivity (DTH) reaction to oxazolone was assessed to evaluate cell-mediated immunity.

Main Results:

• Cycloheximide at 10, 25, and 50 mg/kg i.p. enhanced the direct splenic PFC response.
• Doses of 10, 25, and 50 mg/kg i.p. also led to an augmentation of the DTH reaction to oxazolone.
• Higher doses of cycloheximide (75 and 100 mg/kg i.p.) resulted in a depression of both immune responses.
• A low dose of 5 mg/kg i.p. showed no significant effect on either immune response.

Conclusions:

• Cycloheximide exhibits a biphasic effect on mouse immune responses, acting as an enhancer at moderate doses and a suppressor at higher doses.
• These findings highlight the critical role of drug dosage in modulating immune system activity.
• Further research is warranted to elucidate the precise mechanisms underlying cycloheximide's immunomodulatory effects.